文献
J-GLOBAL ID:202202276346649083
整理番号:22A1740600
Majorの珍しいEGFR変化を有する進行非小細胞肺癌患者に対するダコミチニブ:中国における二重中心,単腕,両腕のコホート試験【JST・京大機械翻訳】
Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China
著者 (12件):
Li Hong-Shuai
(1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
,
Yang Guang-Jian
(2Department of Respiratory Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Ji’nan, China)
,
Cai Yi
(3Independent Researcher, Ellicott City, MD, United States)
,
Li Jun-Ling
(1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
,
Xu Hai-Yan
(1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
,
Zhang Tao
(1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
,
Zhou Li-Qiang
(1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
,
Wang Yu-Ying
(4Department of Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China)
,
Wang Jin-Liang
(4Department of Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China)
,
Hu Xing-Sheng
(1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
,
Yan Xiang
(4Department of Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China)
,
Wang Yan
(1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
資料名:
Frontiers in Pharmacology (Web)
(Frontiers in Pharmacology (Web))
巻:
13
ページ:
919652
発行年:
2022年
JST資料番号:
U7091A
ISSN:
1663-9812
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)